1. How difficult is the test for me or a patient?
The test is noninvasive and relatively easy to administer. An intravenous catheter is placed in a vein in the patient’s arm near the elbow. One test compound is given intravenously through the catheter and another is taken orally in a liquid solution. Five samples of blood are drawn through the catheter for 90 minutes. The catheter is removed after the 90 minute sample is obtained.

2. Where is the test performed?
The test can be administered in the outpatient setting – either in a physican office, infusion center, or any facility with phlebotomy (blood-drawing) capability.

3. Do I need to make any special arrangements, bring an accompanying person, or miss work for this testing?
The test only involves removal of small amounts of blood and you may leave the testing center immediately after the last blood sample, at 90 minutes, has been obtained. Testing does not require sedation, administration of narcotics, or special monitoring.

F.A.Q.

If you are a MD and would like more information on HepQuant please use our request info form here.

NOTE: HepQuant tests have not yet been fully evaluated or reviewed by the US Food and Drug Administration (FDA) and is not currently available for clinical use or commercial sale.

HepQuant Fact

All the major manifestations of liver disease, such as ascites, varices, and encephalopathy, are related to an altered portal circulation. HepQuant tests were designed to assess the portal circulation – test parameters are continuous variables that may be correlated to clinical features or may be followed over time to measure disease progression. HepQuant tests are non-invasive, uses stable (not radioactive) isotopes, and relies on natural, well-defined hepatic functions to measure the portal circulation.

Want more information?
Have Questions?

Contact HepQuant Now